Sucampo Pharma (SCMP) Tops Q4 EPS by 3c

Sucampo Pharma (NASDAQ: SCMP) reported Q4 EPS of $0.21, $0.03 better than the analyst estimate of $0.18. Revenue for the quarter came in at $37.8 million versus the consensus estimate of $37.23 million.

For earnings history and earnings-related data on Sucampo Pharma (SCMP) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Benchmark Reiterates Buy Rating on H World Group Ltd. (HTHT) Following Q2 Print
• Sypris Solutions (SYPR) Reports Q2 Loss of $0.14